Jazz Pharmaceuticals (JAZZ) P/E ratio

P/E ratio today
71.2×

Jazz Pharmaceuticals (JAZZ) trades at 71.2× its earnings per share over the last twelve months. At the end of fiscal 2024 (December 31, 2024) its P/E ratio was 14.2×. That is 29.4% lower than the 20.2× of fiscal 2023. Figures as of 18 Nov 2026, 09:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
71.2×
P/E ratio, fiscal 2024
14.2×
Change on fiscal 2023
−29.4%
Highest on record
176.1×fiscal 2014
Lowest on record
11.1×fiscal 2012
Fiscal years on record
132010–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Jazz Pharmaceuticals P/E ratio, in more detail

Today's figure is 400.2% above the fiscal 2024 year-end.

Across the 13 fiscal year-ends on record (2010–2024), the highest was 176.1× in fiscal 2014 and the lowest 11.1× in fiscal 2012. Today's P/E ratio is higher than at 92% of the 13 fiscal year-ends on record; their median is 17.0×.

History · 13 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Jazz Pharmaceuticals P/E ratio, year by year

Jazz Pharmaceuticals (JAZZ) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today71.2×—$240.71—
2025——$170.00-$5.84
202414.2× 29.4% down$123.15$8.65
202320.2×—$123.00$6.10
2022——$159.31-$3.58
2021——$127.40-$5.52
202039.1× 138.2% up$165.05$4.22
201916.4× 3.3% down$149.28$9.09
201817.0× 0.4% up$123.96$7.30
201716.9× 0.5% down$134.65$7.96
201617.0× 36.7% down$109.03$6.41
201526.9× 84.7% down$140.56$5.23
2014176.1× 388.3% up$163.73$0.93
201336.1× 224.3% up$126.56$3.51
201211.1× 23.2% down$53.25$4.79
201114.5× 39.0% down$38.63$2.67
201023.7×—$19.68$0.83
2009——$7.88-$0.23

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Jazz Pharmaceuticals and comparable companies
CompanyP/E ratio
Neurocrine Biosciences NBIX24.6×
Ascendis Pharma ASND17.8×
ICON ICLR78.0×
Jazz Pharmaceuticals JAZZ71.2×
Solventum SOLV96.7×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals P/E ratio: questions and answers

What is Jazz Pharmaceuticals's P/E ratio?

Jazz Pharmaceuticals (JAZZ) trades at 71.2× its earnings per share over the last twelve months. At the end of fiscal 2024 (December 31, 2024) its P/E ratio was 14.2×. That is 29.4% lower than the 20.2× of fiscal 2023.

Is Jazz Pharmaceuticals's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 92% of the 13 fiscal year-ends on record; their median is 17.0×.

What are the highest and lowest P/E ratio figures on record for Jazz Pharmaceuticals?

Across the 13 fiscal year-ends on record (2010–2024), the highest was 176.1× in fiscal 2014 and the lowest 11.1× in fiscal 2012.

How is Jazz Pharmaceuticals's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Jazz Pharmaceuticals it is on record here for 13 fiscal years, 2010 to 2024.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.